A new experimental medication called Enlicitide has shown powerful cholesterol-lowering effects in a large clinical study. In a phase three trial reported in The NEJM, the once-daily pill reduced levels of low-density lipoprotein (LDL) cholesterol, often called “bad” cholesterol, by as much as...